Komori
Shin-Etsu Chemical (4063) · RiskRestated

Regulatory Risks Related to Investment, Imports and Exports, Commercial Transactions, Labor, Patents, Taxation and Other Areas Across Countries

First written in FY2016. 18 of 19 entries say "Restated". Latest entry: FY2024.

19entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY20242016: 220162017: 420172018: 420182019: 220192020: 220202021: 020212022: 320222023: 120232024: 12024
Same theme, other companies
Business constraints from tighter or changing regulations and litigation across multiple sectorsA theme 346 companies write about · 349 as a headwind · 1 as a tailwind

The whole theme swung hardest in 2026: 22 of 71 companies on the "Worse" side.

124 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 199 companies compared. The sentences above are computed from all 199.Comparing 200 of the theme's 350 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2024RestatedAnnual report

    「In the countries and regions where our group conducts business, it is subject to various applicable laws and regulations relating to investment approvals, import and export controls, commercial transactions, employment, patents, taxation, foreign exchange and other matters. Changes to these laws and regulations could have a significant impact on the performance of our group.」

    Continues to identify regulatory risks relating to investment, imports and exports, commercial transactions, labor, patents, taxation, foreign exchange and other matters in each country.
  2. FY2024-Q2RestatedAnnual report

    「During the first six months of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    States that there have been no new or material changes in regulatory risks relating to investment, imports and exports, commercial transactions, labor, patents, taxation, foreign exchange and other matters in each country.
  3. FY2023-Q2RestatedAnnual report

    「During the first six months of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    States that there have been no new or material changes in regulatory risks relating to investment, imports and exports, commercial transactions, labor, patents, taxation, foreign exchange and other matters in each country.
  4. FY2022RestatedAnnual report

    「In the countries and regions where our group conducts business, it is subject to various applicable laws and regulations relating to investment approvals, import and export controls, commercial transactions, employment, patents, taxation, foreign exchange and other matters. Changes to these laws and regulations could have a significant impact on the performance of our group.」

    Continues to identify regulatory risks relating to investment, imports and exports, commercial transactions, labor, patents, taxation, foreign exchange and other matters in each country.
  5. FY2022-Q3RestatedAnnual report

    「No new business or other risks arose during the cumulative third quarter under review. In addition, there have been no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    States that there have been no new or material changes in regulatory risks relating to investment, imports and exports, commercial transactions, labor, patents, taxation and other matters in each country.
  6. FY2021-Q1RestatedAnnual report

    「During the first quarter of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The disclosure states that there have been no new occurrences or material changes regarding regulatory risks involving investment, imports and exports, commercial transactions, employment, patents and taxation in each country.
  7. FY2020-Q3RestatedAnnual report

    「No new business or other risks arose during the cumulative third quarter under review. In addition, there have been no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    States that there have been no new or material changes in regulatory risks relating to investment, imports and exports, commercial transactions, labor, patents, taxation and other matters in each country. ※quantified=false、materialized=false
  8. FY2020-Q2RestatedAnnual report

    「During the first six months of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The disclosure states that there have been no new occurrences or material changes regarding regulatory risks involving investment, imports and exports, commercial transactions, employment, patents and taxation in each country.
  9. FY2019-Q3RestatedAnnual report

    「No new business or other risks arose during the cumulative third quarter under review. In addition, there have been no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The disclosure states that there have been no new occurrences or material changes regarding regulatory risks involving investment, imports and exports, commercial transactions, employment, patents and taxation in each country.
  10. FY2019-Q2RestatedAnnual report

    「During the first six months of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The disclosure states that there have been no new occurrences or material changes regarding regulatory risks involving investment, imports and exports, commercial transactions, employment, patents and taxation in each country.
  11. FY2019-Q1RestatedAnnual report

    「During the first quarter of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The disclosure states that there have been no new occurrences or material changes regarding regulatory risks involving investment, imports and exports, commercial transactions, employment, patents and taxation in each country.
  12. FY2018RestatedAnnual report

    「In the countries and regions where our group conducts business, it is subject to various applicable laws and regulations relating to investment approvals, import and export controls, commercial transactions, employment, patents, taxation, foreign exchange and other matters. Changes to these laws and regulations could have a significant impact on the performance of our group.」

    The company continues to disclose regulatory risks involving investment, imports and exports, commercial transactions, employment, patents, taxation and foreign exchange in each country.
  13. FY2018-Q3RestatedAnnual report

    「No new business or other risks arose during the cumulative third quarter under review. In addition, there have been no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The disclosure states that there have been no new occurrences or material changes regarding regulatory risks involving investment, imports and exports, commercial transactions, employment, patents and taxation in each country.
  14. FY2018-Q2RestatedAnnual report

    「During the first six months of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The disclosure states that there have been no new occurrences or material changes regarding regulatory risks involving investment, imports and exports, commercial transactions, employment, patents and taxation in each country.
  15. FY2018-Q1RestatedAnnual report

    「During the first quarter of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The disclosure states that there have been no new occurrences or material changes regarding regulatory risks involving investment, imports and exports, commercial transactions, employment, patents and taxation in each country.
  16. FY2017RestatedAnnual report

    「In the countries and regions where our group conducts business, it is subject to various applicable laws and regulations relating to investment approvals, import and export controls, commercial transactions, employment, patents, taxation, foreign exchange and other matters. Changes to these laws and regulations could have a significant impact on the performance of our group.」

    The company continues to disclose regulatory risks involving investment, imports and exports, commercial transactions, employment, patents, taxation and foreign exchange in each country.
  17. FY2017-Q3RestatedAnnual report

    「No new business or other risks arose during the cumulative third quarter under review. In addition, there have been no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The disclosure states that there have been no material changes regarding regulatory risks involving investment, imports and exports, commercial transactions, employment, patents and taxation in each country.
  18. FY2017-Q2RestatedAnnual report

    「During the first six months of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The disclosure states that there have been no material changes regarding regulatory risks involving investment, imports and exports, commercial transactions, employment, patents and taxation in each country.
  19. FY2016First statedAnnual report

    「In the countries and regions where our group conducts business, it is subject to various applicable laws and regulations relating to investment approvals, import and export controls, commercial transactions, employment, patents, taxation, foreign exchange and other matters. Changes to these laws and regulations could have a significant impact on the performance of our group.」

    The disclosure lists multiple legal and regulatory areas relevant to its global operations.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Shin-Etsu Chemical's next results are scheduled for 2026-10-27. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Regulatory Risks Related to Investment, Imports and Exports, Commercial Transactions, Labor, Patents, Taxation and Other Areas Across Countries | Shin-Etsu Chemical Co.,Ltd. (4063) | Komori